2024-07-11 12:24:34
“After evaluating all the evidence in the case, the court decides to find Joanas Bikulčienė guilty,” said Vilnius District Court judge Arūnas Bartkus, who announced the verdict on Thursday.
In addition, she will have to pay 20 thousand to her former workplace, the National Blood Center. EUR non-pecuniary damage.
The judge noted that at the time of the events mentioned in the case, J. Bikulčienė was the head of the National Blood Center, she is a person equivalent to a civil servant, and as the head should have acted for the benefit of this institution.
Together with J. Bikulčienės, businessman Antanas Petrošius was convicted – he was awarded 22 thousand for aiding in abuse. 200 euros.
Both convicts will have to pay 5 thousand each to the National Blood Center for the services of a lawyer. euros.
The pre-trial investigation in this case regarding the sale of unused blood plasma in 2018. started by the Special Investigation Service, after the investigation, J. Bikulčienė resigned from her position at the National Blood Center soon after.
“One of the sources of income for the National Blood Center was the sale of unused, excess blood plasma for treatment. It was because of the realization of this plasma that this pre-trial investigation began. Questions arose as to whether the defendants’ decisions were made legally,” said judge A. Bartkus.
During the transfer of the case to the court, the officials said that J. Bikulčienė is suspected of trying to help a private company to monopolize the collection of blood plasma and the supply of blood preparations in Lithuania.
in 2018 a tender was announced for the purchase of blood plasma, although the court believes that such a tender was not mandatory, the National Blood Center could choose how to sell the plasma. The management declared that this method is the most suitable because it allows to attract the most buyers, create competition and ensure the best price. The tender was won by a Latvian company, with whom procedures for the negotiation of the contract were carried out.
It was during the coordination of procedures that Solis Tribus was established, shortly after the establishment, an offer was submitted to the National Blood Center, the offer was accepted, and the contract coordination procedures with the Latvian company were terminated, without specifying the reasons why the procedures were terminated.
Judge A. Bartkus noted that “Solis Tribus” was a completely new company, it had neither employees, nor infrastructure, nor licenses, nor experience in this business. The main shareholder of “Solis Tribus” was A. Petrošius, who was convicted in this case with J. Bikulčiene.
in 2020 The case of D. Bikulčienė and A. Petrošius was completed and referred to the court for consideration.
The judgment of the Vilnius District Court is not final and may be appealed.
2024-07-11 12:24:34